Save the Date 2026 and Beyond: CLSG Plenary Meeting and Upcoming Conferences

Upcoming Hematology Conferences in 2026:

Upcoming CLSG Plenary Meetings in 2027 and 2028:

  • March 17–18, 2027 (Hotel Don Giovanni, Prague, Czech Republic)
  • March 22–23, 2028

Upcoming HEMATOLOGY Conferences in Prague in 2027 and 2028:

  • January 27–29, 2027
  • January 26–28, 2028

CLSG Plenary Program


Polivy + BR: Termination of Reimbursement (Effective September 1, 2025)

The medicinal product Polivy, in combination with bendamustine and rituximab (Polivy + BR), was previously granted temporary reimbursement as a Highly Innovative Medicinal Product ("VILP") under administrative proceedings (Ref. Nos. SUKLS180061/2020 and SUKLS118045/2021). Please be advised that this public health insurance coverage expired on August 31, 2025, and is no longer in effect as of September 1, 2025.

For more information (in Czech)


XXXVII Olomouc Hematology Days 2025: Congress Review

We invite you to explore a comprehensive review of the highlights from the XXXVII Olomouc Hematology Days. Access the expert recap, including key takeaways and session summaries, via this link.


Hematology 2025: Participant Perspectives

This year’s Prague "Hematology 2026" brought together a diverse range of experts, including clinicians, researchers, and healthcare professionals from both the Czech Republic and abroad. Follow this link to explore the insights, observations, and key takeaways shared by our attendees.


Highlights from the 17th CLSG Plenary Meeting in 2025

The 17th CLSG Plenary Meeting featured a diverse range of expert contributions from both Czech and international speakers. Key highlights included the latest advances in mantle cell lymphoma (MCL) and marginal zone lymphomas. The program also presented complex case reports highlighting diagnostic challenges, the importance of multidisciplinary collaboration, and new real-world evidence. Beyond therapeutic innovations, the conference focused on optimizing care pathways across hematology departments to ensure high-quality, standardized treatment. Listen to details.

Program

Invitation